Dr. Qinjian Zhao got his undergraduate and graduate training in pharmaceutical sciences in Peking University (1981 – 1989). Then he moved on to pursue a Ph.D. degree in Biochemistry in The Catholic University of America, Washington, DC (1989-1993). Subsequently, he did post-doctoral training in School of Medicine, Johns Hopkins University (1993-1997), focusing on protein structure and enzyme function. In 1997, Qinjian joined Merck Research Lab, Bioprocess R&D, working on the analytical and structural aspects of recombinant protein based vaccines, such as Recombivax HB and HPV vaccine/Gardasil. In vitro relative potency assays and developing and characterizing key immunochemical reagents are the main area of expertise – in support of vaccine development. After ~14 years’ work at Merck (1997-2011), Dr. Zhao joined Xiamen University in 2011, as a distinguished professor associated with the state “Thousand Talent Program”, working on diagnostics and vaccine/biologics development. Dr. Qinjian Zhao co-authored over 50 peer reviewed papers and 4 book chapters.